SLIDESHOW
Data Trends 2024: Transgender and Gender-Diverse Care
August 14, 2024|Federal Practitioner
Author and Disclosure Information
Reviewed by:
Sarah Meadows, PhD
RAND Corporation
Santa Monica, CA
Dr. Meadows has no relevant financial relationships to disclose.
A study of nearly 5000 veterans aged ≥ 65 years who received VHA care found that veterans who are TGD had significantly higher rates of depression, cancer (the most significant difference being prostate, 9.6% vs 3.8%), Alzheimer disease, and social stressors compared with their cisgender peers. However, the 2 groups had similar rates for other conditions including diabetes, atherosclerosis, venous thromboembolism, PTSD, HIV, and rheumatoid arthritis.
Understanding the primary causes of death in veterans who are transgender can inform resource allocation, policy development, and research efforts. Tailored interventions may enhance health care access and quality or promote community support. Clinician education on these issues is essential to improving health outcomes and reducing mortality disparities for these individuals in this population.
VHA clinicians and veterans who are TGD were interviewed regarding the challenges they experience with prescribing or receiving gender-affirming hormone therapy.
- A study of nearly 5000 veterans aged ≥ 65 years who received VHA care found that veterans who are TGD had significantly higher rates of depression, cancer (the most significant difference being prostate, 9.6% vs 3.8%), Alzheimer disease, and social stressors compared with their cisgender peers. However, the 2 groups had similar rates for other conditions including diabetes, atherosclerosis, venous thromboembolism, PTSD, HIV, and rheumatoid arthritis.
- Understanding the primary causes of death in veterans who are transgender can inform resource allocation, policy development, and research efforts. Tailored interventions may enhance health care access and quality or promote community support. Clinician education on these issues is essential to improving health outcomes and reducing mortality disparities for these individuals in this population.
- VHA clinicians and veterans who are TGD were interviewed regarding the challenges they experience with prescribing or receiving gender-affirming hormone therapy.
- A study of nearly 5000 veterans aged ≥ 65 years who received VHA care found that veterans who are TGD had significantly higher rates of depression, cancer (the most significant difference being prostate, 9.6% vs 3.8%), Alzheimer disease, and social stressors compared with their cisgender peers. However, the 2 groups had similar rates for other conditions including diabetes, atherosclerosis, venous thromboembolism, PTSD, HIV, and rheumatoid arthritis.
- Understanding the primary causes of death in veterans who are transgender can inform resource allocation, policy development, and research efforts. Tailored interventions may enhance health care access and quality or promote community support. Clinician education on these issues is essential to improving health outcomes and reducing mortality disparities for these individuals in this population.
- VHA clinicians and veterans who are TGD were interviewed regarding the challenges they experience with prescribing or receiving gender-affirming hormone therapy.
Item 1 of 7